Reverter JC - Search Results

1

Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels: studies under flow conditions.

Galán AM, Hernández MR, Bozzo J, Reverter JC, Estelrich J, Roy T, Mazzara R, Ordinas A, Escolar G. Galán AM, et al. Among authors: reverter jc. Transfusion. 1998 Nov-Dec;38(11-12):1004-10. doi: 10.1046/j.1537-2995.1998.38111299056307.x. Transfusion. 1998. PMID: 9838928

2

A variant of Glanzmann's thrombasthenia which fails to express a GPIIb-IIIa related epitope that is recognized by a specific monoclonal antibody (C17).

Escolar G, Diaz-Ricart M, Garrido M, Reverter JC, Villamor N, Sanz C, Maragall S, Castillo R, Ordinas A, Nurden AT. Escolar G, et al. Among authors: reverter jc. Br J Haematol. 1992 Aug;81(4):545-51. doi: 10.1111/j.1365-2141.1992.tb02990.x. Br J Haematol. 1992. PMID: 1382548

3

Recombinant human erythropoietin treatment improves platelet function in uremic patients.

Cases A, Escolar G, Reverter JC, Ordinas A, Lopez-Pedret J, Revert L, Castillo R. Cases A, et al. Among authors: reverter jc. Kidney Int. 1992 Sep;42(3):668-72. doi: 10.1038/ki.1992.333. Kidney Int. 1992. PMID: 1405344 Free article.

4

Hemostatic effect of platelet von Willebrand factor.

Castillo R, Escolar G, Monteagudo J, Reverter JC, Ordinas A. Castillo R, et al. Among authors: reverter jc. Haemostasis. 1992;22(5):233-5. doi: 10.1159/000216328. Haemostasis. 1992. PMID: 1478532

5

Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system.

Escolar G, Font J, Reverter JC, López-Soto A, Garrido M, Cervera R, Ingelmo M, Castillo R, Ordinas A. Escolar G, et al. Among authors: reverter jc. Arterioscler Thromb. 1992 Feb;12(2):196-200. doi: 10.1161/01.atv.12.2.196. Arterioscler Thromb. 1992. PMID: 1543693

6

Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Monteagudo J, Pereira A, Reverter JC, Pijoan J, Tusell J, Puig L, Ordinas A, Castillo R. Monteagudo J, et al. Among authors: reverter jc. Thromb Haemost. 1991 Nov 1;66(5):515-9. Thromb Haemost. 1991. PMID: 1803613

7

[Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].

Cases A, Escolar G, Reverter JC, Garrido M, Ordinas A, López-Pedret J, Castillo R, Revert L. Cases A, et al. Among authors: reverter jc. Med Clin (Barc). 1990 Nov 17;95(17):644-7. Med Clin (Barc). 1990. PMID: 2089202 Spanish.

8

Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome.

Monteagudo J, Pereira A, Roig S, Reverter JC, Ordinas A, Castillo R. Monteagudo J, et al. Among authors: reverter jc. Am J Hematol. 1990 Jan;33(1):46-9. doi: 10.1002/ajh.2830330109. Am J Hematol. 1990. PMID: 2104558

9

Intraoperative investigation of von Willebrand factor structure and function in orthotopic liver transplantation. The Liver Transplantation Group.

Monteagudo J, Reverter JC, Mateo D, Seoane R, Mazzara R, Escolar G, Pereira A, Castillo R, Visa J. Monteagudo J, et al. Among authors: reverter jc. Transplant Proc. 1990 Aug;22(4):1531-2. Transplant Proc. 1990. PMID: 2389391 No abstract available.

10

Anti-K1 of the IgA class associated with Morganella morganii infection.

Pereira A, Monteagudo J, Rovira M, Mazzara R, Reverter JC, Castillo R. Pereira A, et al. Among authors: reverter jc. Transfusion. 1989 Jul-Aug;29(6):549-51. doi: 10.1046/j.1537-2995.1989.29689318457.x. Transfusion. 1989. PMID: 2749877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters